<html>
<head>PUBMED IDs for INK4D</head>
<body bgcolor='#C5F0F2'><h1>INK4D</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9031081/'>Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.</a> November 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9070222/'>Expression of G1-phase cell cycle genes during hematopoietic lineage.</a> February 3  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9244358/'>The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.</a> July 10  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/21528268/'>Molecular analysis of INK4 genes in breast carcinomas.</a> October 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9328438/'>Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice.</a> October 27  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9432039/'>Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16beta, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard.</a> January 31  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10208428/'>Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.</a> April 20  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10390011/'>Mutation testing in melanoma families: INK4A, CDK4 and INK4D.</a> July 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10651629/'>Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4.</a> January 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12040438/'>Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).</a> June 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12203782/'>Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.</a> August 31  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12698196/'>Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.</a> April 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15894583/'>Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation.</a> May 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15948116/'>Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.</a> June 11  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16152586/'>Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.</a> September 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16322758/'>Convergence of vitamin D and retinoic acid signalling at a common hormone response element.</a> December 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16582618/'>p19INK4D and cell death.</a> April 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17070905/'>Expression analysis of PCNA gene in chronic myelogenous leukemia--combined application of siRNA silencing and expression arrays.</a> October 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18029087/'>Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway.</a> November 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18276842/'>P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1.</a> February 16  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19401813/'>Expression of p18(INK4C) is down-regulated in human pituitary adenomas.</a> July 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21901251/'>Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival.</a> January 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23536727/'>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis.</a> April 2  2013<br></body></html>
